Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a ...
A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...
Scottish Labour pledge to tackle ‘gross inequalities’ in cancer screening - The pledge comes ahead of the Holyrood elections ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...
New EAU 2026 research finds prostate cancer screening has little impact on quality of life or anxiety in men. Learn more ...
Plus, how to tell if it needs healing in the first place.
6d
"I was fighting to survive": Patients still struggle with preauthorization despite promise of reform
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and ...
Energy, recovery and motivation may shift with age, but they are not fixed outcomes. Evidence points to simple, sustainable ...
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results